303 related articles for article (PubMed ID: 28002448)
1. Unique Molecular Patterns Uncovered in Kawasaki Disease Patients with Elevated Serum Gamma Glutamyl Transferase Levels: Implications for Intravenous Immunoglobulin Responsiveness.
Wang Y; Li Z; Hu G; Hao S; Deng X; Huang M; Ren M; Jiang X; Kanegaye JT; Ha KS; Lee J; Li X; Jiang X; Yu Y; Tremoulet AH; Burns JC; Whitin JC; Shin AY; Sylvester KG; McElhinney DB; Cohen HJ; Ling XB;
PLoS One; 2016; 11(12):e0167434. PubMed ID: 28002448
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory cytokines as predictors of resistance to intravenous immunoglobulin therapy in Kawasaki disease patients.
Sato S; Kawashima H; Kashiwagi Y; Hoshika A
Int J Rheum Dis; 2013 Apr; 16(2):168-72. PubMed ID: 23773640
[TBL] [Abstract][Full Text] [Related]
3. The prognostic role of abnormal liver function in IVIG unresponsiveness in Kawasaki disease: a meta-analysis.
Liu L; Yin W; Wang R; Sun D; He X; Ding Y
Inflamm Res; 2016 Feb; 65(2):161-8. PubMed ID: 26645912
[TBL] [Abstract][Full Text] [Related]
4. Prediction of intravenous immunoglobulin resistance in patients with Kawasaki disease according to the duration of illness prior to treatment.
Ha KS; Lee J; Lee KC
Eur J Pediatr; 2020 Feb; 179(2):257-264. PubMed ID: 31713683
[TBL] [Abstract][Full Text] [Related]
5. Serum amyloid A as a biomarker for immunoglobulin resistance in Kawasaki disease.
Huang XB; Zhao S; Liu ZY; Xu YY; Deng F
Ann Med; 2023; 55(2):2264315. PubMed ID: 37870383
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of C-reactive protein to albumin ratio as a biomarker for initial and repeated intravenous immunoglobulin resistance in a large cohort of Kawasaki disease patients: a prospective cohort study.
Liu X; Wang L; Zhou K; Shao S; Hua Y; Wu M; Liu L; Wang C
Pediatr Rheumatol Online J; 2021 Mar; 19(1):24. PubMed ID: 33712036
[TBL] [Abstract][Full Text] [Related]
7. Prediction of intravenous immunoglobulin resistance in Kawasaki disease in children.
Wu S; Liao Y; Sun Y; Zhang CY; Zhang QY; Yan H; Qi JG; Liu XQ; Chen YH; Wang YL; Li XY; Jin HF; Du JB
World J Pediatr; 2020 Dec; 16(6):607-613. PubMed ID: 32232677
[TBL] [Abstract][Full Text] [Related]
8. The factors affecting the disease course in Kawasaki disease.
Arslanoglu Aydin E; Ertugrul I; Bilginer Y; Batu ED; Sonmez HE; Demir S; Arici ZS; Sag E; Alehan D; Ozen S
Rheumatol Int; 2019 Aug; 39(8):1343-1349. PubMed ID: 31139951
[TBL] [Abstract][Full Text] [Related]
9. Predictors for Intravenous Immunoglobulin Resistance in Patients with Kawasaki Disease.
Li W; Zhang L; Wang Z; He X; Lin H; Wang Y; Yuan J; Xie X; Zhang X; Qin Y; Huang P
Int J Clin Pract; 2022; 2022():2726686. PubMed ID: 35989868
[TBL] [Abstract][Full Text] [Related]
10. Evolution of laboratory values in patients with Kawasaki disease.
Tremoulet AH; Jain S; Chandrasekar D; Sun X; Sato Y; Burns JC
Pediatr Infect Dis J; 2011 Dec; 30(12):1022-6. PubMed ID: 21817952
[TBL] [Abstract][Full Text] [Related]
11. Sonographic gallbladder abnormality is associated with intravenous immunoglobulin resistance in Kawasaki disease.
Chen CJ; Huang FC; Tiao MM; Huang YH; Lin LY; Yu HR; Yang KD; Huang YC; Chen CC; Chang WC; Kuo HC
ScientificWorldJournal; 2012; 2012():485758. PubMed ID: 22792043
[TBL] [Abstract][Full Text] [Related]
12. A comparison of the predictive validity of the combination of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio and other risk scoring systems for intravenous immunoglobulin (ivig)-resistance in Kawasaki disease.
Takeshita S; Kanai T; Kawamura Y; Yoshida Y; Nonoyama S
PLoS One; 2017; 12(5):e0176957. PubMed ID: 28542183
[TBL] [Abstract][Full Text] [Related]
13. [Expression of interleukin-17A in serum of children with intravenous immunoglobulin-resistant Kawasaki disease and its clinical significance].
Li SY; Ding Y
Zhongguo Dang Dai Er Ke Za Zhi; 2023 Mar; 25(3):244-249. PubMed ID: 36946157
[TBL] [Abstract][Full Text] [Related]
14. Kawasaki disease in Turkish children: a single center experience with emphasis on intravenous immunoglobulin resistance and giant coronary aneurysms.
Yılmazer MM; Özdemir R; Meşe T; Küçük M; Öner T; Devrim İ; Bayram N; Güven B; Tavlı V
Turk J Pediatr; 2019; 61(5):648-656. PubMed ID: 32104995
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of albumin for intravenous immunoglobulin resistance in a large cohort of Kawasaki disease patients.
Zhang R; Shuai S; Zhang H; Cai J; Cui N; Tang M; Xing S; Gao Y; Liu X; Yang X
Ital J Pediatr; 2023 Jun; 49(1):78. PubMed ID: 37357258
[TBL] [Abstract][Full Text] [Related]
16. Circulating platelet-neutrophil aggregates play a significant role in Kawasaki disease.
Ueno K; Nomura Y; Morita Y; Eguchi T; Masuda K; Kawano Y
Circ J; 2015; 79(6):1349-56. PubMed ID: 25787672
[TBL] [Abstract][Full Text] [Related]
17. Serum alanine aminotransferase level and intravenous immunoglobulin resistance in patients with kawasaki disease.
Masuda H; Ae R; Koshimizu TA; Kosami K; Makino N; Matsubara Y; Sasahara T; Nakamura Y
Clin Rheumatol; 2022 Oct; 41(10):3125-3133. PubMed ID: 35798922
[TBL] [Abstract][Full Text] [Related]
18. Exploring the relationship between pyroptosis, infiltrating immune cells and Kawasaki disease with resistance to intravenous immunoglobulin (IVIG) via bioinformatic analysis.
Xie Y; Han B
Immunobiology; 2022 Sep; 227(5):152261. PubMed ID: 36029669
[TBL] [Abstract][Full Text] [Related]
19. Importance of C-reactive protein level in predicting non-response to additional intravenous immunoglobulin treatment in children with Kawasaki disease: a retrospective study.
Iwashima S; Kimura M; Ishikawa T; Ohzeki T
Clin Drug Investig; 2011; 31(3):191-9. PubMed ID: 21456105
[TBL] [Abstract][Full Text] [Related]
20. Treatment response in Kawasaki disease is associated with sialylation levels of endogenous but not therapeutic intravenous immunoglobulin G.
Ogata S; Shimizu C; Franco A; Touma R; Kanegaye JT; Choudhury BP; Naidu NN; Kanda Y; Hoang LT; Hibberd ML; Tremoulet AH; Varki A; Burns JC
PLoS One; 2013; 8(12):e81448. PubMed ID: 24324693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
